Get started
Author

Maximilian Koblischke

Observed name: Koblischke, Maximilian
Observed institution: Medical University of Vienna
ORCID: 0000-0003-1223-4990
Observed ORCID: 0000-0003-1223-4990
OpenAlex ID: A5024502000
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
2021 · Daniel Mrak, Selma Tobudic, et al. · Annals of the Rheumatic Diseases · 243
SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 + T cell responses
2021 · Benedikt Agerer, Maximilian Koblischke, et al. · Science Immunology · 180
Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial
2021 · Roman Reindl-Schwaighofer, Andreas Heinzel, et al. · JAMA Internal Medicine · 128
PDF
Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease Severity
2020 · Maximilian Koblischke, Marianna T. Traugott, et al. · Frontiers in Medicine · 73
PDF
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
2022 · Michael Bonelli, Daniel Mrak, et al. · Annals of the Rheumatic Diseases · 61
PDF
B Cell Depletion and SARS‐CoV ‐2 Vaccine Responses in Neuroimmunologic Patients
2021 · Barbara Kornek, Fritz Leutmezer, et al. · Annals of Neurology · 49
Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection
2018 · Maximilian Koblischke, Karin Stiasny, et al. · Frontiers in Immunology · 34
PDF
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial
2022 · Daniel Mrak, Daniela Sieghart, et al. · Nature Communications · 32
PDF
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study
2022 · Daniel Mrak, Elisabeth Simader, et al. · Annals of the Rheumatic Diseases · 32
Protein structure shapes immunodominance in the CD4 T cell response to yellow fever vaccination
2017 · Maximilian Koblischke, Maria S. Mackroth, et al. · Scientific Reports · 25
PDF
Torque teno viruses exhaust and imprint the human immune system via the HLA-E/NKG2A axis
2024 · Hannes Vietzen, Cara Simonitsch, et al. · Frontiers in Immunology · 22
PDF
CD4 T cell responses to flaviviruses
2018 · Judith H. Aberle, Maximilian Koblischke, et al. · Journal of Clinical Virology · 17
CD4 T Cell Determinants in West Nile Virus Disease and Asymptomatic Infection
2020 · Maximilian Koblischke, Felicia S. Spitzer, et al. · Frontiers in Immunology · 13
PDF
Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination
2022 · Lorenz Schubert, Maximilian Koblischke, et al. · Cancers · 9
PDF
Immune Response after mRNA COVID-19 Vaccination in Lung Transplant Recipients: A 6-Month Follow-Up
2022 · Selma Tobudic, Alberto Benazzo, et al. · Vaccines · 8
PDF
Corrigendum: Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection
2018 · Maximilian Koblischke, Karin Stiasny, et al. · Frontiers in Immunology · 6
PDF
Purine nucleobases enhance CD8 + T cell effector function
2025 · Jakob-Wendelin Genger, Ben Haladik, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients
2023 · Christa Lichtensteiger, Maximilian Koblischke, et al. · Journal of Autoimmunity · 1
PDF
Immune response after mRNA COVID-19 vaccination in heart transplant recipients: long-term follow-up and evaluation of a third vaccination
2022 · Selma Tobudic, Keziban Uyanik-Ünal, et al. · European Journal of Preventive Cardiology · 1
PDF
Specificities of human CD4+ T cell responses to the live attenuated yellow fever virus vaccine (17D-204)
2016 · Koblischke, Maximilian · University of Vienna
Works count: 21
Citation count: 935
H-index: 13
I10-index: 13
Year
Topic
Type